IRF5 and myocardial ischemia: Inhibition of IRF5 activity effectively reduces the expression of pro‐inflammatory cytokines, attenuates the inflammatory response in post‐infarcted tissues, and promotes healing and tissue remodelling of the infarcted myocardium, which may make IRF5 a potential therapeutic target for the treatment of IHD.71